Dipòsit Digital de Documents de la UAB
Publication
Artículo científico (JournalArticle)
IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status
A relationship between polymorphisms in genes encoding interleukin 7 (IL-7) and its cellular receptor (IL-7R) and antiretroviral therapy (ART)-associated immune recovery in HIV subjects has been previously reported. However, details of this relationship remain unclear, and the association of these polymorphisms with circulating IL-7/IL-7R levels is scarce. Here, we explored whether IL-7/IL-7R axis was associated with quantitative CD4 T-cell recovery in HIV-infected subjects. IL-7/IL-7R polymorphisms were assessed by genotyping, and multiple inheritance models were used to estimate both, their association with low pre-ART CD4 T-cell counts and incomplete immune recovery status after 48 weeks of suppressive ART. Integrated data from genetic variants association and soluble plasma IL-7/IL-7R quantification suggest that IL-7/IL-7R genotype expression could alter the homeostatic balance between soluble and membrane-bound receptors. The haplotype analyses indicates that allele combinations impacts pre-ART circulating CD4 T-cell counts, immune recovery status and the absolute increment of CD4 T-cell counts. The knowledge about how IL-7/IL-7R axis is related to quantitative CD4 T-cell recovery and immune recovery status after initiating ART could be useful regarding T-cell reservoirs investigations in HIV subjects.
Project:
Instituto de Salud Carlos III RD12-0017-0005
,
Instituto de Salud Carlos III RD16-0025-0002
,
Ministerio de Economía y Competitividad RD16/0025/0006
,
Instituto de Salud Carlos III RD16-0025-0019
,
Instituto de Salud Carlos III RD16-0025-0020
,
Instituto de Salud Carlos III INT15-226
,
Instituto de Salud Carlos III PI10-02635
,
Instituto de Salud Carlos III PI13-0796
,
Instituto de Salud Carlos III PI14-1693
,
Instituto de Salud Carlos III PI16-00503
,
Instituto de Salud Carlos III PI16-00684
,
Instituto de Salud Carlos III PI19-01337
,
Instituto de Salud Carlos III CPII014-00025
,
Ministerio de Economía y Competitividad EUIN2017-89297
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2014/SGR-250
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-948
,
Agència de Gestió d'Ajuts Universitaris i de Recerca PERIS/SLT002-16-0010101